我们以提供高质量稳定同位素为荣,为全球范围内的广泛科学研究项目提供支持。我们的研究活动经常在同行评议的科学期刊上发表,无论是独立发表还是与其他研究团体合作发表。我们是一家灵活的研发公司,这两项活动受到同等的重视和重视。
Omicron Biochemicals, Inc. develops new and improved methods to introduce stable isotopes, primarily 13C, 2H, 15N and 18O, into biologically-important compounds. We specialize in the synthesis of labeled carbohydrates, nucleosides, and their derivatives, but will undertake the synthesis of other classes of compounds on a custom basis. Our particular strengths lie in the preparation of site-specifically labeled compounds, but we are also capable of producing uniformly labeled products.
The approaches used in synthesis include chemical, chemi-enzymatic, enzymatic and biological methods. We also collaborate with other laboratories as needed to develop new products or distribute our products.
We take pride in providing quality stable isotopes in support of a wide range of scientific research programs worldwide. Our research activities frequently result in publication in peer-reviewed scientific journals, either independently or in collaboration with other research groups. We are a flexible research and development company, with both activities receiving equal weight and attention.